This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Laurent Leksell, Elekta’s chairman of the board, said the company needs “new lea...
Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’...
Tandem is following competitor Insulet’s lead with the second automated insulin ...
Staar’s job cuts come “amid ongoing macroeconomic and geopolitical challenges th...
The pathologists group wants the HHS to terminate the regulation in light of an ...
The acquisition will add dialysis-related water testing to Quest’s portfolio and...
Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up ...
An industry source said “most, if not all” of the people at CDRH who were recent...
The brain-computer interface technology personalizes therapy based on an individ...
The lawsuit claims Natera aggressively recruited bioinformatics scientists from ...
VitalConnect will use the money to commercialize the monitor, which detects arrh...
Interim CEO Brent Shafer said the medical products maker is ready to begin a new...
Expanding parts inventory and logistics capabilities will support later cutoff t...
The cuts at the FDA’s device center could add “months, if not years” to the time...
Scott Whitaker sent a letter to the HHS calling for staff cuts at the FDA to be ...
Mazzola’s retirement plan comes less than two months after CFO William Kelly lef...
Philips forecast a double-digit sales decline in China for the first half of 202...
Wall Street analysts said current tariffs should be “manageable” for the sector ...
CEO Geoff Martha said Medtronic would submit its application for urological proc...
Lynlee Brown, a global trade partner at EY, outlined several strategies for devi...
J.P. Morgan analysts said the findings of J&J’s investigation “could significant...
Medtronic will use the technology to develop PEEK interbody spine fusion devices...
District Judge John Bates wrote the removals harm “everyday Americans, and most ...
Executives expect a new label indication and a hoped-for easing of hospital capa...